Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.
  • ArrayPharmacy
  • call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:









  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

Dr. Swapna Goday, M.D.

Board certified in Medical Oncology & Hematology
Specialties:

Solid tumors (Breast, GI, GU) | Hemostasis| Thrombosis | Malignant Hematology

Locations:

Southlake | Lewisville

Dr. Swapna Goday MD is a hematology and oncology specialist with over 17 years of experience. Dr. Goday graduated in 2003. She is licensed to practice by the state board in Texas with 7 years of clinical experience. Her focus is in Solid tumors (Breast, GI, GU), Hemostasis & Thrombosis, Malignant Hematology.

ACADEMIC /PROFESSIONAL APPOINTMENTS/ WORK HISTORY:

2018-2019

Assistant Professor, Hematology Oncology, University of Texas Southwestern Medical Center, Dallas,TX

2012-2018

Assistant Professor, Hematology Oncology, Temple University School of Medicine, Allegheny Health Network, Pittsburgh, PA

2013-2018

Medical Director, WPH Anticoagulation Management Center

Education

2009-2012

Fellow, Hematology Oncology, Allegheny General Hospital/Western Pennsylvania Hospital, Medical Education Consortium, Pittsburgh, PA

2006-2009

Internal Medicine Resident, Western Pennsylvania Hospital, Pittsburgh, PA

2005-2006

Master of Public Health (MPH), Major: Health Administration, Eastern Tennessee State University (ETSU), Johnson City, TN

1998-2003

Bachelor of Medicine and Bachelor of Surgery (M.B.B.S), Osmania Medical College, Hyderabad, India

Board Certification

– Board Certified in Hematology, October 2012

– Board Certified in Medical Oncology, October 2012

– American Board of Internal Medicine Certified, Sept. 2009

– ECFMG Certification, Feb. 2005

Honors and Awards

– CALGB Summer Group Meeting, 2011 Travel Grant, Boston, MA June 2011

– Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society) Coagulation Disorders
Workshop, Orlando, Florida December 2, 2010

– Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society) Coagulation Disorders
Workshop, Diagnosis and Management of Coagulation Disorders on April 21, 2009, at San Diego, California.

– Gold Medal in Microbiology in 2000 for outstanding performance.

– First Division Honors in Medical school

– First Division in Pharmacology, Microbiology, Pathology, Forensic Medicine, ENT, Ophthalmology, Gynecology
and Obstetrics, Medicine and Pediatrics in MBBS.

– Received certificate of Merit awarded by the Ministry of Human Resources & Development, Government of India as
a part of National Scholarship Scheme in 1997-1998

Previous Professional Positions and Appointments

2003-2004

Duty Medical Officer, Poulomi Hospitals, Hyderabad, India

2002-2003

Internal Medicine House Officer, Department of Medicine, Osmania General Hospital – Teaching Hospital of Osmania Medical College, Hyderabad, India

Committee Memberships

– Medical Director – WPH Anticoagulation Management Center

– Education Committee Member

– Society for the Advancement of Blood Management

– Transfusion Committee member-Allegheny Health Network

– Anticoagulation Committee Member- Allegheny Health Network

– Cancer Committee Member –Western Pennsylvania Hospital

Professional and Society Memberships

– American Society of Hematology, Associate Member

– American Society of Clinical Oncology, Associate Member

– Member of International Society on Thrombosis and Hemostasis( ISTH)

– Texas Medical Association

– Dallas County Medical Society

– American College of Physicians

– American Medical Association

– MPH Student Association ETSU Alumni

Presentations at National Meetings

Clinical Vignette Presentation, May 15, 2009 – Spinal Neurosarcoidosis at Society of General Internal Medicine (SGIM) at Florida

Medical Jeopardy Competition, Participant in ACP Medical Jeopardy Pennsylvania Chapter Scientific Meeting, Dec. 2008

Poster Presentations

Hepatocellular carcinoma presenting as an atrial mass ; S. Goday., A. Achilleos, K. Foust, C. Herb –Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008

Pseudoaneurysm of the Superior Gluteal Artery occurring as a complication of Bone marrow Biopsy; A. Sinha, S. Goday, A. Achilleos – Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008

EBV infection masquerading as Behcet’s disease; S. Goday, R. Volosky, A. Achilleos – Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008

Spinal Neurosarcoidosis; S. Goday, A. Achilleos, S. Komerally, R. Arora- Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008

Research

Principal Investigator : ATTRACT Study ( NIH Funded) in collaboration with Washington University School of Medicine: Acute Venous Thrombosis –Thrombus removal with adjunctive catheter directed Thrombolysis .Final results published in NEJM -Dec 2017

Principal Investigator: BRIDGE Study ( NIH ,National Heart ,lung and Blood Institute funded) in collaboration with Duke Clinical Research Institute :Bridging Anticoagulation in patients who require temporary interruption of warfarin therapy for an elective invasive procedure or therapy-Final results published in NEJM – August 2015

Principal Investigator : Comparison of Oral anticoagulants for extended VEnous Thromboembolism (COVET) in collaboration with Duke Clinical Research Institute Principal Investigator: Thomas Ortel, MD Co-Principal Investigator: Lana Castellucci, MD Co-Principal Investigator: David Garcia, MD –Await finalization of protocol

Co -investigator:Alliance Venous Thromboembolism-Clinical Trial–Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)-A Randomized Effectiveness Trial- Currently enrolling

Principal Investigator: Retrospective analysis of indications of IVC filter placement at Allegheny Health Network –Presented at local chapter –PSOH (Pennsylvania Society of Oncology and Hematology)

Outcomes of Hematopoietic Stem Cell Transplant Recipients Admitted to a Medical Intensive Care Unit (MICU) as Predicted by the Hematopoietic Cell Transplantation Co morbidity Index (HCTCI).S. Miller, J Rossetti, E. Sahovic, J. Lister, S. Goday Publications

Using Smartphones to Access Medical Reference Information.

Swapna Goday MD, MPH Onc Live, Published September 12, 2011

An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis.

Gastrointestinal Cancer Research 2013 May-Jun; 6(3): 90–92 Rohit rao, Santosh K Sadashiv, Swapna Goday, Dulabh Monga

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE Investigators. N Engl J Med. 2015 Aug 27;373(9):823-33.

Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis

Suresh Vedantham, M.D etal .ATTRACT investigators. N Engl J Med. 2017 Dec 7 ;377:2240-2252

Cancer Screening Guidelines

Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

Learn More

Save Your Hair During Chemo

We offer the Chemo Cold Caps Solution for patients seeking to save their hair while undergoing chemotherapy.  The Chemotherapy Cold Caps program can be accessed at any of our North Texas clinics. At Choice Cancer Care we know that being diagnosed with...

Learn More

Learn About Your Options

Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

Learn More